Trials / Completed
CompletedNCT01294033
Effect of Supplemental Oxygen on Maximal Oxygen Consumption in Patients With Chronic Obstructive Pulmonary Disease
Effect of Therapeutic Hyperoxia on Maximal Oxygen Consumption and Perioperative Risk Stratification in Patients With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Maximal consumption of oxygen (VO2max) during exercise is used in patients with chronic obstructive pulmonary disease (COPD) to stratify perioperative risk. However, the impact of supplemental oxygen to prevent hypoxemia during exercise on maximal oxygen consumption and other ventilatory parameters during maximal exercise in the resting normoxic Chronic Obstructive Pulmonary Disease population is poorly defined. The investigators performed a randomized controlled trial in patients with COPD who underwent cardiopulmonary exercise tests on room air and supplemental oxygen. The investigators compared maximal oxygen consumption and other ventilatory parameters in each individual subject under the two conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fractional inspired oxygen (FiO2) 0.21 | |
| OTHER | Fractional inspired oxygen 0.28 | Supplemental oxygen |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2011-02-11
- Last updated
- 2017-03-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01294033. Inclusion in this directory is not an endorsement.